Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors

<p>Supplemental Figure S7. CLDN6 expression in ovarian and endometrial cancer tissue samples.</p>

Đã lưu trong:
Chi tiết về thư mục
Tác giả chính: Martina S.J. McDermott (15206951) (author)
Tác giả khác: Neil A. O'Brien (15206954) (author), Benjamin Hoffstrom (15206957) (author), KeWei Gong (15206960) (author), Ming Lu (15206963) (author), Jun Zhang (15206966) (author), Tong Luo (15206969) (author), Min Liang (15206972) (author), Weiping Jia (15206975) (author), Jenny J. Hong (15206978) (author), Kevin Chau (15206981) (author), Simon Davenport (15206984) (author), Bin Xie (15206987) (author), Michael F. Press (15206990) (author), Richard Panayiotou (15206993) (author), Abram Handly-Santana (15206996) (author), Joan S. Brugge (9710515) (author), Leonard Presta (15206999) (author), John Glaspy (15207002) (author), Dennis J. Slamon (15047067) (author)
Được phát hành: 2025
Những chủ đề:
Các nhãn: Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
_version_ 1849927633730535424
author Martina S.J. McDermott (15206951)
author2 Neil A. O'Brien (15206954)
Benjamin Hoffstrom (15206957)
KeWei Gong (15206960)
Ming Lu (15206963)
Jun Zhang (15206966)
Tong Luo (15206969)
Min Liang (15206972)
Weiping Jia (15206975)
Jenny J. Hong (15206978)
Kevin Chau (15206981)
Simon Davenport (15206984)
Bin Xie (15206987)
Michael F. Press (15206990)
Richard Panayiotou (15206993)
Abram Handly-Santana (15206996)
Joan S. Brugge (9710515)
Leonard Presta (15206999)
John Glaspy (15207002)
Dennis J. Slamon (15047067)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Martina S.J. McDermott (15206951)
Neil A. O'Brien (15206954)
Benjamin Hoffstrom (15206957)
KeWei Gong (15206960)
Ming Lu (15206963)
Jun Zhang (15206966)
Tong Luo (15206969)
Min Liang (15206972)
Weiping Jia (15206975)
Jenny J. Hong (15206978)
Kevin Chau (15206981)
Simon Davenport (15206984)
Bin Xie (15206987)
Michael F. Press (15206990)
Richard Panayiotou (15206993)
Abram Handly-Santana (15206996)
Joan S. Brugge (9710515)
Leonard Presta (15206999)
John Glaspy (15207002)
Dennis J. Slamon (15047067)
author_role author
dc.creator.none.fl_str_mv Martina S.J. McDermott (15206951)
Neil A. O'Brien (15206954)
Benjamin Hoffstrom (15206957)
KeWei Gong (15206960)
Ming Lu (15206963)
Jun Zhang (15206966)
Tong Luo (15206969)
Min Liang (15206972)
Weiping Jia (15206975)
Jenny J. Hong (15206978)
Kevin Chau (15206981)
Simon Davenport (15206984)
Bin Xie (15206987)
Michael F. Press (15206990)
Richard Panayiotou (15206993)
Abram Handly-Santana (15206996)
Joan S. Brugge (9710515)
Leonard Presta (15206999)
John Glaspy (15207002)
Dennis J. Slamon (15047067)
dc.date.none.fl_str_mv 2025-11-25T13:00:30Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30706646
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Figure_S7_from_Preclinical_Efficacy_of_the_Antibody_Drug_Conjugate_CLDN6_23-ADC_for_the_Treatment_of_CLDN6-Positive_Solid_Tumors/30706646
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Therapeutic Research and Development
Biological Agents & Therapies
Antibody-drug conjugates
Gynecological Cancers
Endometrial cancer
Ovarian cancer
Translational Research
dc.title.none.fl_str_mv Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Supplemental Figure S7. CLDN6 expression in ovarian and endometrial cancer tissue samples.</p>
eu_rights_str_mv openAccess
id Manara_74af075d72b2bc2e0f4ee9d3086e63b0
identifier_str_mv 10.1158/1078-0432.30706646
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30706646
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid TumorsMartina S.J. McDermott (15206951)Neil A. O'Brien (15206954)Benjamin Hoffstrom (15206957)KeWei Gong (15206960)Ming Lu (15206963)Jun Zhang (15206966)Tong Luo (15206969)Min Liang (15206972)Weiping Jia (15206975)Jenny J. Hong (15206978)Kevin Chau (15206981)Simon Davenport (15206984)Bin Xie (15206987)Michael F. Press (15206990)Richard Panayiotou (15206993)Abram Handly-Santana (15206996)Joan S. Brugge (9710515)Leonard Presta (15206999)John Glaspy (15207002)Dennis J. Slamon (15047067)CancerTherapeutic Research and DevelopmentBiological Agents & TherapiesAntibody-drug conjugatesGynecological CancersEndometrial cancerOvarian cancerTranslational Research<p>Supplemental Figure S7. CLDN6 expression in ovarian and endometrial cancer tissue samples.</p>2025-11-25T13:00:30ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30706646https://figshare.com/articles/figure/Figure_S7_from_Preclinical_Efficacy_of_the_Antibody_Drug_Conjugate_CLDN6_23-ADC_for_the_Treatment_of_CLDN6-Positive_Solid_Tumors/30706646CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307066462025-11-25T13:00:30Z
spellingShingle Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
Martina S.J. McDermott (15206951)
Cancer
Therapeutic Research and Development
Biological Agents & Therapies
Antibody-drug conjugates
Gynecological Cancers
Endometrial cancer
Ovarian cancer
Translational Research
status_str publishedVersion
title Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_full Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_fullStr Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_full_unstemmed Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_short Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_sort Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
topic Cancer
Therapeutic Research and Development
Biological Agents & Therapies
Antibody-drug conjugates
Gynecological Cancers
Endometrial cancer
Ovarian cancer
Translational Research